CD8A and neoplasm: Preclinical models have shown that TKI-mediated inhibition of these pathways can lead to a reduction in tumor-associated macrophages and a corresponding increase in CD8+ cytotoxic T-cell infiltration, ultimately converting “cold” tumors into immune-responsive microenvironments [121,134].